HLIO
Helios Technologies, Inc.
HLIO has the edge over RKLB overall, supported by stronger valuation and lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB's outlook is improving, though it still trails on the overall score.
HLIO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HLIO's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HLIO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $47.69 | — |
| Current | 20x | $47.69 | — |
| Cheap | 21x | $50.21 | +5.3% |
| Fair | 37x | $88.21 | +85% |
| Expensive | 53x | $126 | +163% |
Historical ranges are pointers, not guarantees.
HLIO's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
HLIO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HLIO, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HLIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.30 | +40% |
| Q3 2026 | $2.36 | +134% |
| Q2 2026 | $2.14 | +106% |
| Q1 2026 | $1.82 | +64% |
| Q4 2025 | $1.45 | +24% |
| Q3 2025 | $1.01 | -11% |
| Q2 2025 | $1.04 | +16% |
| Q1 2025 | $1.11 | +11% |
| Q4 2024 | $1.17 | +2.6% |
HLIO has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
HLIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $229.7M | +4.3% |
| Q2 2026 | $231.9M | +9.1% |
| Q1 2026 | $228.4M | +17% |
| Q4 2025 | $210.8M | +17% |
| Q3 2025 | $220.3M | +13% |
| Q2 2025 | $212.5M | -3.4% |
| Q1 2025 | $195.5M | -7.8% |
| Q4 2024 | $179.5M | -7.2% |
HLIO's revenue has grown year over year for five quarters in a row: $230M last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +12 points |
| Q2 2026 | 14% | +3.7 points |
| Q1 2026 | 13% | +4.4 points |
| Q4 2025 | 12% | +4.8 points |
| Q3 2025 | 0.6% | -11 points |
| Q2 2025 | 10% | -1.5 points |
| Q1 2025 | 8.7% | -0.9 points |
| Q4 2024 | 7.4% | +1.3 points |
HLIO has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over HLIO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
HLIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.4M | +74% |
| Q2 2026 | $30.6M | -3.2% |
| Q1 2026 | $17.2M | +33% |
| Q4 2025 | $40.5M | +43% |
| Q3 2025 | $18.6M | -35% |
| Q2 2025 | $31.6M | +22% |
| Q1 2025 | $12.9M | +4.9% |
| Q4 2024 | $28.3M | +14% |
HLIO has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
HLIO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.8x | Healthy |
| Q4 2024 | 1.8x | Healthy |
HLIO's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.9 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HLIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.8 | Oversold |
| Stochastic | 3.3 | Oversold |
HLIO's weekly RSI is 25 (oversold) and its Stochastic is 3 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
HLIO PE vs Industrials Sector
| Metric | HLIO | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 24x | 16% below |
| PE % | 12 | 58 | 46 pts below |
HLIO is trading at 20x earnings, a 16% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
HLIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.1 | 24% below |
| 20 week MA | $71.6 | 33% below |
| 50 week MA | $70.2 | 32% below |
| 100 week MA | $56.0 | 15% below |
| 200 week MA | $53.9 | 11% below |
HLIO is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over HLIO on trend strength, trading above more of its moving averages.
HLIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.5 | $52.8 | +16% |
| 2021 | $52.8 | $103.1 | +95% |
| 2022 | $103.1 | $54.8 | -47% |
| 2023 | $54.8 | $45.4 | -17% |
| 2024 | $45.4 | $45.0 | -0.8% |
| 2025 | $45.0 | $55.5 | +23% |
| 2026 YTD | $55.5 | $47.7 | -14% |
HLIO has finished lower in three of the last six years. It's down 14% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over HLIO on returns for 2026, with the stronger performance.